Imports, Independence, and Innovation: Redefining Pharma Strategy Across MENA
The pharmaceutical supply chain across the Middle East and North Africa is undergoing a profound transformation. For decades, the region relied overwhelmingly on foreign imports, with countries like Saudi Arabia and the UAE sourcing up to 80–90% of all medications from abroad. But the post-pandemic world, disrupted logistics networks, and ambitious national visions for self-reliance are rewriting the playbook entirely.
